FTV
Fortive Corp
$62.20
+1.05 (+1.72%)
At close · Jul 10
Market Cap
$18.96B
Shares
304,861,021
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.16B
+1.9%
FY2025
Net Income
$579.2M
-30.5%
FY2025
Gross Margin
63.5%
-0.7pp
FY2025
Operating Margin
17.32%
-0.2pp
FY2025
Diluted EPS
$1.73
-26.7%
FY2025
Operating Cash Flow
$1.08B
-29.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $4.24B | $4.16B | $4.08B | $3.91B | $5.83B | $5.25B | $4.63B | $4.56B | $6.45B | $5.76B | $5.38B | $6.18B | $6.34B | |
| — | $1.56B | $1.52B | $1.46B | $1.44B | $2.46B | $2.25B | $2.03B | $2.08B | $1.61B | $2.83B | $2.69B | $3.18B | $3.29B | |
| — | $2.68B | $2.64B | $2.62B | $2.48B | $3.36B | $3.01B | $2.61B | $2.48B | $2.19B | $2.92B | $2.69B | $3B | $3.05B | |
| — | — | 63.5% | 64.18% | 63.29% | 57.73% | 57.23% | 56.29% | 54.41% | 33.88% | 50.75% | 49.93% | 48.55% | 48.12% | |
| — | $261.7M | $259.2M | $251.3M | $237M | $401.5M | $354.8M | $320.7M | $320.3M | $278.1M | $369.3M | $351M | $377.7M | $387.6M | |
| — | $1.67B | $1.66B | $1.65B | $1.67B | $1.96B | $1.84B | $1.75B | $1.72B | $1.26B | $1.41B | $1.27B | $1.35B | $1.42B | |
| — | — | $368M | $369M | $367M | $382M | $321M | $310M | $261M | $105M | $65M | $85M | $89M | $90M | |
| — | $443.2M | $437.6M | $430.9M | $426.2M | $465.6M | $395.5M | $384M | $341.5M | $174.2M | $158.3M | $160.9M | $176.9M | $178M | |
| — | — | — | — | — | — | — | — | — | $6M | $16M | $15M | $12M | — | |
| — | -$1.93B | -$1.92B | -$1.9B | -$1.9B | -$2.36B | — | — | — | — | — | — | — | — | |
| — | $746.6M | $720.2M | $716.3M | $574M | $987.4M | $812.8M | $539.4M | $443.9M | $645.3M | $1.14B | $1.06B | $1.27B | $1.25B | |
| — | — | 17.32% | 17.55% | 14.67% | 16.95% | 15.47% | 11.64% | 9.73% | 10% | 19.86% | 19.74% | 20.55% | 19.65% | |
| — | $1.19B | $1.16B | $1.15B | $1B | $1.45B | $1.21B | $923.4M | $785.4M | $819.5M | $1.3B | $1.22B | $1.45B | $1.42B | |
| — | -$120.1M | -$120.5M | -$152.8M | -$123.5M | -$98.3M | $103.2M | $148.5M | $142.6M | $77.2M | $88.7M | $46.4M | $0 | $0 | |
| — | $5.6M | $2.5M | -$57.2M | -$17.4M | -$15.6M | -$14.1M | -$2.4M | -$5.4M | -$2.3M | $4M | -$4.8M | — | — | |
| — | — | — | — | — | $0 | $0 | $5.3M | $0 | $0 | $8M | $0 | $0 | — | |
| — | — | $0 | -$39.4M | -$17.3M | -$17.3M | — | — | — | — | — | — | — | — | |
| — | $632.1M | $602.2M | $506.3M | $433.1M | $873.5M | $677.5M | $1.51B | $336.7M | $565.8M | $1.07B | $1.01B | $1.27B | $1.28B | |
| — | $75.6M | $69.5M | $23.8M | $24.7M | $118.3M | $63.3M | $55.5M | $68.6M | $75.6M | $189.3M | $270.3M | $405.9M | $395.8M | |
| — | $543.7M | $579.2M | $832.9M | $865.8M | $755.2M | $608.4M | $1.61B | $738.9M | $2.91B | $1.04B | $872.3M | $863.8M | $883.4M | |
| — | — | 13.93% | 20.41% | 22.12% | 12.96% | 11.58% | 34.81% | 16.19% | 45.16% | 18.15% | 16.22% | 13.98% | 13.94% | |
| — | — | — | — | $865.8M | $755.2M | $573.9M | $1.54B | $669.9M | $2.88B | $1.04B | $872.3M | — | — | |
| — | $648.1M | $753.3M | $693.6M | $865.4M | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | — | $1.74 | $2.39 | $2.46 | $1.60 | $1.24 | $3.45 | $1.50 | $6.28 | $1.90 | $1.59 | $1.58 | $1.61 |
| USD/shares | $2.90 – $3.00* | — | $1.73 | $2.36 | $2.43 | $1.58 | $1.23 | $3.38 | $1.48 | $6.19 | $1.87 | $1.58 | $1.58 | $1.61 |
| shares | — | — | 332M | 349.2M | 352.5M | 472.94M | 463.12M | 447.73M | 445.61M | 458.48M | 551.05M | 548.2M | 547.41M | 547.41M |
| shares | — | — | 334.6M | 352.8M | 355.6M | 478.78M | 467.5M | 476.39M | 451.18M | 465.38M | 559.14M | 550.74M | 547.41M | 547.41M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2025: $3.22B in buybacks, $933M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
5.22×
Scientific & Technical Instruments median 5.31×
EV/EBIT
29.59×
Scientific & Technical Instruments median 28.03×
P/E (TTM)
37.25×
Scientific & Technical Instruments median 42.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Intelligent Operating Solutions | $2,856,300,000 | $2,793,200,000 | $2,684,500,000 | $2,466,100,000 | $2,169,400,000 | $1,883,700,000 | $1,898,900,000 | $1,576,300,000 |
| Advanced Healthcare Solutions | $1,302,800,000 | $1,287,700,000 | $1,229,400,000 | $1,207,300,000 | $1,236,400,000 | $1,099,400,000 | $856,600,000 | $322,700,000 |
| Precision Technologies | — | — | — | $2,152,300,000 | $1,848,900,000 | $1,651,300,000 | $1,808,400,000 | $1,901,400,000 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| North America | $2,491,100,000 | $2,416,800,000 | $2,292,400,000 | — | — | — | — | — |
| Asia Pacific | $730,100,000 | $733,300,000 | $727,200,000 | — | — | — | — | — |
| EMEA | $725,800,000 | $721,100,000 | $697,600,000 | — | — | — | — | — |
| Latin America | $212,100,000 | $209,700,000 | $196,700,000 | — | — | — | — | — |
| China | — | — | — | $702,100,000 | $650,700,000 | $534,100,000 | $501,200,000 | $476,800,000 |
| United States | — | — | — | $3,136,800,000 | $2,683,000,000 | $2,436,600,000 | $2,394,200,000 | $1,875,800,000 |
| Countries Excluding United States and China | — | — | — | $1,986,800,000 | $1,921,000,000 | $1,663,700,000 | $1,668,500,000 | $1,447,800,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Product | $3,341,300,000 | $3,290,900,000 | $3,157,700,000 | $4,920,100,000 | $4,496,100,000 | $3,956,700,000 | $3,922,500,000 | $3,360,500,000 |
| Service | $817,800,000 | $790,000,000 | $756,200,000 | $905,600,000 | $758,600,000 | $677,700,000 | $641,400,000 | $439,900,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Intelligent Operating Solutions | $738,300,000 | $708,000,000 | $629,900,000 | $519,400,000 | $408,500,000 | $317,800,000 | $289,000,000 | $350,300,000 |
| Advanced Healthcare Solutions | $138,600,000 | $138,500,000 | $83,800,000 | $95,600,000 | $101,900,000 | $2,100,000 | -$72,000,000 | $5,300,000 |
| Industrial Technologies | — | — | — | — | — | — | $553,900,000 | $525,600,000 |
| Precision Technologies | — | $500,000,000 | $544,200,000 | $503,600,000 | $408,000,000 | $321,700,000 | $324,600,000 | $381,500,000 |
| Professional Instrumentation | — | — | — | — | — | — | $547,900,000 | $744,600,000 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Intelligent Operating Solutions | 25.8% | 25.3% | 23.5% | 21.1% | 18.8% | 16.9% | 15.2% | 22.2% |
| Advanced Healthcare Solutions | 10.6% | 10.8% | 6.8% | 7.9% | 8.2% | 0.2% | -8.4% | 1.6% |
| Precision Technologies | — | — | — | 23.4% | 22.1% | 19.5% | 17.9% | 20.1% |
Key facts
CIK
1659166
CUSIP
34959J108
13F (30d)
63 filings
40 filers
Visit website
Investor relations